This initiative shall be led by Dr Narinder Singh, who has long years of experience in research and technology, new business development and has done pioneering work in molecular diagnostics, biosimilar development, drug discovery in technology solutions, licensing of pre-clinical assets and high value contract research, technology consulting( biotech, life sciences), and business advisory.
He has a proven track record of driving new business, initiating strategic partnerships, and managing talent in multi-disciplinary teams.
He is a Ph.D in Genetics and has led teams in world-class organizations in the areas of molecular diagnostic product development, genome sequencing and stem cell therapy.
He has driven efforts to collaborate with health professionals, policy makers and scientists to advance the implementation of genomic medicine in India, the Middle East, and some Asian countries.
During his stint in these MNCs, he has networked with reputed scientists, hospitals, institutions providing world-class healthcare facilities and entities engaged in developing next-gen medical devices and equipment and technologies.
He is co-founder of Cellagility and mbaessaynation
He is a native of Himachal Pradesh and has widely travelled in India and abroad
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.